These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8742506)

  • 1. 7-chlorokynurenic acid prevents in vitro epileptiform and neurotoxic effects due to kainic acid.
    Domenici MR; Longo R; Sagratella S
    Gen Pharmacol; 1996 Jan; 27(1):113-6. PubMed ID: 8742506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
    Domenici MR; Marinelli S; Sagratella S
    Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changes.
    Longo R; Domenici MR; Scotti de Carolis A; Sagratella S
    Life Sci; 1995; 56(21):PL409-14. PubMed ID: 7537844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate.
    Stone TW
    Br J Pharmacol; 1990 Dec; 101(4):847-52. PubMed ID: 1964821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Mg2+ blockade of synaptically activated N-methyl-D-aspartate receptor-channels in CA1 pyramidal neurons in kainic acid-lesioned rat hippocampus.
    Chen Y; Chad JE; Cannon RC; Wheal HV
    Neuroscience; 1999; 88(3):727-39. PubMed ID: 10363813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular studies on the role of N-methyl-D-aspartate receptors in epileptiform activity recorded from the kainic acid-lesioned hippocampus.
    Ashwood TJ; Wheal HV
    Neurosci Lett; 1986 Jun; 67(2):147-52. PubMed ID: 2873533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for synaptic and network plasticity in controlling epileptiform activity in CA1 in the kainic acid-lesioned rat hippocampus in vitro.
    Bernard C; Wheal HV
    J Physiol; 1996 Aug; 495 ( Pt 1)(Pt 1):127-42. PubMed ID: 8866357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of non-NMDA and NMDA receptors to graded bursting activity in the CA1 region of the hippocampus in a chronic model of epilepsy.
    Simpson LH; Wheal HV; Williamson R
    Can J Physiol Pharmacol; 1991 Jul; 69(7):1091-8. PubMed ID: 1683263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic effects of the excitatory amino acid antagonist cis-2,3 piperidine-dicarboxylic acid depend on non-N-methyl-d-aspartate receptors.
    Sagratella S; Frank C; de Carolis AS
    Arch Int Pharmacodyn Ther; 1989; 299():28-34. PubMed ID: 2549894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMD 95885, a new eliprodil analogue with higher affinity for the N-methyl-D-aspartate (NMDA) receptor.
    Leibrock J; Prücher H; Rautenberg W
    Pharmazie; 1997 Jun; 52(6):479-80. PubMed ID: 9260271
    [No Abstract]   [Full Text] [Related]  

  • 12. Kynurenic acid antagonism of kainate following mossy fibre lesions of rat hippocampus.
    Stone TW
    Neuroreport; 1990; 1(3-4):218-20. PubMed ID: 1966606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influence of excitatory amino acid antagonists on penicillin-induced epileptiform bursting in rat hippocampal slices.
    Sagratella S; Frank C; de Carolis AS
    Pharmacol Biochem Behav; 1990 Apr; 35(4):999-1001. PubMed ID: 2189145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones.
    Vyklický L; Benveniste M; Mayer ML
    J Physiol; 1990 Sep; 428():313-31. PubMed ID: 2172523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of kynurenic acid and 2-APV suppression of epileptiform activity in rat hippocampal slices.
    Stone TW
    Neurosci Lett; 1988 Jan; 84(2):234-8. PubMed ID: 2893320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox sites of NMDA receptors can modulate epileptiform activity in hippocampal slices from kainic acid-treated rats.
    Quesada O; Hirsch J; Ben-Ari Y; Bernard C
    Neurosci Lett; 1996 Jul; 212(3):171-4. PubMed ID: 8843100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of NMDA receptors in rat spinal cord motoneurons.
    Palecek JI; Abdrachmanova G; Vlachová V; Vyklick L
    Eur J Neurosci; 1999 Mar; 11(3):827-36. PubMed ID: 10103076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptiform activity and EPSP-spike potentiation induced in rat hippocampal CA1 slices by repeated high-K(+): involvement of ionotropic glutamate receptors and Ca(2+)/calmodulin-dependent protein kinase II.
    Semyanov A; Godukhin O
    Neuropharmacology; 2001; 40(2):203-11. PubMed ID: 11114399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the relative potency of two glycine antagonists on NMDA-induced depolarizations in BRSC and ARCS.
    Corsi M; Bettelini L; Fina P; Trist DG
    Ann N Y Acad Sci; 1997 May; 812():187-8. PubMed ID: 9186738
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of adenosinergic drugs on the epileptiform and neurotoxic effects of N-methyl-d-aspartate: comparison with the effects of MK801.
    Frank C; Scotti de Carolis A; Sagratella S
    Arch Int Pharmacodyn Ther; 1994; 327(1):3-12. PubMed ID: 7944826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.